Navigation Links
Genetic Mutation Implicated in Charcot-Marie-Tooth Disease

Around 1 in 2500 people suffer from hereditary Charcot-Marie-Tooth (CMT) disease. The role of genetics in this disease has remained unclear. However researchers from the// Flanders Interuniversity Institute for Biotechnology (VIB) connected to the University of Antwerp have now reported that mutations in mitofusin 2 are the major cause of the disease. These important findings could also be the basis of a new genetic test.

Weakening the muscles

Charcot-Marie-Tooth (CMT) disease is the most common hereditary disorder of the peripheral nervous system, leading to a weakening of the muscles in the lower legs, feet and hands as the nerves that run from the spinal cord to the muscles die off. The syndrome is extremely variable: some patients hardly notice it, while others become confined to a wheelchair. Today, only palliative treatment is available − there are as yet no effective therapies for preventing, retarding, or stopping the course of the disease.

Knowledge of genes makes fast diagnosis possible CMT embraces a heterogeneous group of disorders, all of which are caused by mutations in certain genes. Identifying these genes is fundamental to improving diagnosis. This is important for assessing what the further course of the disease might be for a given patient. But it is also important for providing genetic advice and prenatal and pre-implantation diagnosis for couples who desire to have children but whose families have a history of the disease. Research by Vincent Timmerman's group underpinned the currently existing genetic test for CMT1A. However, for a long time scientists did not know which gene causes CMT2. In 2004, the VIB researchers in Antwerp, in collaboration with German and American research groups, showed that mitofusin 2 (MFN2) was altered in a large number of CMT2 patients.

Major cause

The current research of Kristien Verhoeven and Kristl Claeys, under the direction of Vincent Tim
'"/>




Page: 1 2

Related medicine news :

1. Genetic Dentistry: Your Dentist may be able to grow you a new set of Teeth.
2. Genetic influence in menopause
3. Genetics and cholesterol levels
4. Genetics helps in attacking cancer
5. Genetic disorder related with sleep patterns
6. Genetic innovation
7. Genetic tests for cancer
8. Genetic indicates memory
9. Genetic mutation to the fountain of youth discovered
10. Genetic differences found between Male and Female brains
11. Alcoholism Influenced By Both Genetics & Family Environment

Post Your Comments:
(Date:12/2/2009)...INGTON, Va., Dec. 2 From more than...ive us meaning, joy and peace, the LIFE Foundation...t conducted using the popular photo-sharing Web si... a video montage on the LIFE Foundation,s Web site...ntestants submitted one photo and a caption to Fli...
(Date:12/2/2009)...STOWN, N.J., Dec. 2 Wats...unced that the Federal Trade Commission (FTC) has ...nt relating to Watson,s pending acquisition of pri...ination of the Hart Scott Rodino waiting period, t...tion. The parties have now obtained all regulator...
(Date:12/2/2009)...Advisory for Thursday, Dec. 3 ,, Head of Army... Meeting of Army Wounded Warriors; Army Embraces R... ,, WASHINGTON, Dec. 2 /PRNewswire-USNewswire/ ...l Organization on Disability: ,, WHAT: Wounde...nded Warrior (AW2) program,s National Organization...
(Date:12/2/2009)...NGTON and REDMOND, Wash., Dec. 2 /PRNewswire/ -... companies will collaborate to give caregivers sin...tion necessary for providing ongoing care after pa... their families better tools for managing patients...ute care organization to adopt Microsoft Amalga Un...
(Date:12/2/2009)...STOWN, N.J., Dec. 2 Wats...unced that it has completed the acquisition of Arr...purchase creates a financially strong, global spec...in annual revenues and operations in more than 20 ...enefits to Watson shareholders as a result of this...
Breaking Medicine News(10 mins):Health News:Wonders of Life Photo Contest Winners Announced 2Health News:Wonders of Life Photo Contest Winners Announced 3Health News:Watson Receives FTC Clearance for Arrow Acquisition 2Health News:Wounded Vets, CAREER Counselors Gather in Washington as Obama Announces Afghanistan Troop Buildup 2Health News:Golden Living Kick-Starts Post-Acute Health IT with Microsoft HealthVault and Amalga UIS Connection 2Health News:Golden Living Kick-Starts Post-Acute Health IT with Microsoft HealthVault and Amalga UIS Connection 3Health News:Golden Living Kick-Starts Post-Acute Health IT with Microsoft HealthVault and Amalga UIS Connection 4Health News:Watson Completes Acquisition of Arrow Group 2Health News:Watson Completes Acquisition of Arrow Group 3Health News:Watson Completes Acquisition of Arrow Group 4Health News:Watson Completes Acquisition of Arrow Group 5
...1Q09 Xyrem(R) net sales of $18 million are 56% hig...9 million are 50% lower than 1Q08 , , PALO ALTO, ...q: JAZZ ) today announced financial results for ... 2008. Xyrem(R) (sodium oxybate) oral solution net...
...YL, North Wales, May 7 Glan Clywd Hospital will s... more advanced radiotherapy treatments using Rapid...nt machines from Varian Medical Systems (NYSE: V...form of radiotherapy that extends more advanced ca...
...NVER, May 7 Air Methods Corporation (Nasdaq: AI... What: Air Methods Corporation Webcast, ... Where: http://www.videonewswire.com/event... to participate during the live Webcast, the call,...
...APEL HILL, N.C., May 7 When the unpredictable i...fficials warn that the seemingly lessening threat ...andemic contingency plans already, nearly one-thir... LLC primary research study on "Managing Workforce...
...affirms Full Year 2009 Revenue and Increases Low-e... , First Quarter 2009 Highlights: , , , , ...over-year and up 6.8% on a constant currency basis...of $11.2 million, up 17.2% year-over-year and up 1...
...th Annual Building Safety Week is May 3-9, 2009 ...y Week 2009, the International Code Foundation is ...o save money and prevent disasters. , , (Photo:...e water supply for granted all thanks to the enfor...
Other Medicine News:Health News:Jazz Pharmaceuticals, Inc. Announces First Quarter 2009 Financial Results 2Health News:Jazz Pharmaceuticals, Inc. Announces First Quarter 2009 Financial Results 3Health News:Jazz Pharmaceuticals, Inc. Announces First Quarter 2009 Financial Results 4Health News:Jazz Pharmaceuticals, Inc. Announces First Quarter 2009 Financial Results 5Health News:Jazz Pharmaceuticals, Inc. Announces First Quarter 2009 Financial Results 6Health News:Cancer Patients in North Wales to Gain Access to Varian's RapidArc Radiotherapy Treatments 2Health News:Corporate Pandemic Preparedness Experts from Roche & PSEG to Advise Savvy Business Leaders May 15 2Health News:Corporate Pandemic Preparedness Experts from Roche & PSEG to Advise Savvy Business Leaders May 15 3Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 2Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 3Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 4Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 5Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 6Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 7Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 8Health News:Daily Dose: Safe Water News You Can Use 2Health News:Daily Dose: Safe Water News You Can Use 3
(Date:12/2/2009)... , NANJING, China, Dec. 2 /PRNewswire-As...the "Company") (NYSE: SCR ), a leading pharmaceu...ufacturing, and marketing of branded,generic and p...d that its,subsidiary Jiangsu Yanshen Biological T...suspended production of all its products in order ...
(Date:12/2/2009)... , EAST HANOVER, N.J., Dec. 2 /PRNewswir...uding a late-breaking presentation on Tasigna®... myeloid leukemia, demonstrate the strength of the...are of patients. ,, The new data, at the 51st ...g and Exposition, highlight the company,s current ...
(Date:12/1/2009)..., TEMECULA, Calif., Dec. 1 /PRNewswire-FirstCal...tin Board: PSTX) announced today that it has appoi...ef Financial Officer, Treasurer and Corporate Secr...CFO since 2008. Prior to joining Patient Safety T...ance, Chief Financial Officer, Treasurer and Corpo...
Breaking Medicine Technology:Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 2Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Patient Safety Technologies, Inc. Appoints Marc L. Rose, CPA (PA), Chief Financial Officer 2Live Broadcast of Drug Rehab Graduation at Canadian Narconon 50339 1Live Broadcast of Drug Rehab Graduation at Canadian Narconon 50339 2BioSpecifics Technologies Corp Added to Russell 3000 and Russell 2000 Indexes 12832 1BioSpecifics Technologies Corp Added to Russell 3000 and Russell 2000 Indexes 12832 2Depression Anxiety Bad for the Heart 50336 1Depression Anxiety Bad for the Heart 50336 2Depression Anxiety Bad for the Heart 50336 3
OneTouch® UltraSoft® Lancets
OneTouch® Fine Point™ Lancets
Microtainer Quikheel Lancet
HEMOCHRON Jr. Signature+ Microcoagulation System
Medicine Products: